Dumont & Blake Investment Advisors LLC cut its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,353 shares of the medical research company’s stock after […]
Dumont & Blake Investment Advisors LLC cut its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 3.0% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 4,353 shares of the medical research company’s stock after selling 135 shares during […]
Bell Bank lowered its holdings in shares of Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,716 shares of the medical research company’s stock after selling 146 shares during the quarter. Bell […]
Bell Bank cut its holdings in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.8% in the fourth quarter, Holdings Channel reports. The institutional investor owned 1,716 shares of the medical research company’s stock after selling 146 shares during the quarter. Bell Bank’s holdings in Charles River Laboratories International were worth $406,000 at […]
Bell Bank decreased its position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) by 7.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 1,716 shares of the medical research company’s stock after selling 146 shares during the period. Bell Bank’s holdings in Charles River […]